< Back to News

Celebrating Success: OxValue.AI Accomplishes Valuation of Nuclearmedix’s Revolutionary Technology

29 May 2023

Celebrating Success: OxValue.AI Accomplishes Valuation of Nuclearmedix’s Revolutionary Technology

Company News-

We are thrilled to reveal the successful valuation of Nuclearmedix, a pioneering company in the cutting-edge field of Next-gen Targeted Radio-theranostics, based in the Imperial College London. This milestone achievement was accomplished utilizing our state-of-the-art technology valuation tool!
Nuclearmedix’s remarkable leadership team is spearheaded by co-founders Professor Eric Aboagye FMedSc and Dr. Ruisi Fu. Prof. Eric Aboagye, a fellow of the Academy of Medical Sciences in the UK, holds prominent roles as the Director of CRUK-EPSRC-MRC-NIHR Comprehensive Imaging Centre and as a professor at the Imperial College London. Alongside him, his co-founder Dr. Ruisi Fu, a Post-Doc Researcher at the Imperial College London, takes charge as the Aboagye lab’s Chemistry Lead.
Nuclearmedix's primary focus is the deployment of its revolutionary technology to combat cancer. Their Next-gen Targeted Radio-theranostics approach offers a novel and promising solution for the management and treatment of this devastating disease. This breakthrough technology is set to reshape the landscape of cancer therapeutics and holds immense potential for patients worldwide.
Our technology valuation tool's comprehensive analysis validates Nuclearmedix's significant contributions to medical sciences and radiopharmaceutical development. We look forward to witnessing Nuclearmedix's continued growth and the transformative impact of its pioneering technology on global health! 

About OxValue.AI
OxValue.AI is a technology spin-off company from the University of Oxford that provides an efficient and practical set of industry tools for technology and startup valuation. It offers a differentiated approach to valuation using a methodology developed by senior academics for more than eight years. A novel theoretical framework is combined with machine learning, and uses proprietary samples of around 20 years of global data to produce fast, accurate and objective assessments of a technology's worth.
About Professor Xiaolan Fu
Professor Xiaolan Fu, founder of OxValue.AI, is a Professor of Technology and International Development at the University of Oxford, a Fellow of the Academy of Social Sciences, and the Founding Director of the Technology and Management Centre for Development (TMCD).
She has authored several books and received awards for her research on innovation, technology policy, and management. Her research interests include valuation, knowledge transfer, inclusive development, and green innovation. She was appointed by the Secretary-General to the Governing Council of the Technology Bank of the United Nations.